Partnering
Contact
Contact Information
Join Us
EN
CN
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
Southeast Asia Business
News
Company News
Partner News
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Investor Communication
Home
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
News
Company News
Partner News
Investors
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Investor Communication
Partnering
Contact
Contact Information
Join Us
EN
CN
Can-fite Biopharma
Can-fite Biopharma
Product
Related News
【Can-Fite BioPharma-Product CF101】New Phase III Psoriasis Data Showing Superior Safety & Improved Efficacy Presented by Kol Dr. Papp at the 31st European Academy of Dermatology
2022-09-12
【Can-Fite BioPharma-Product CF102】 Can-Fite’S Drug Namodenoson(CF102) Approved for Compassionate Use Treatment of Advanced Liver Cancer Patients in Romania
2022-08-23
